Gulf Pharmaceutical Industries P.S.C. (ADX:JULPHAR)

United Arab Emirates · Delayed Price · Currency is AED

1.020

-0.020 (-1.92%)

At close: Sep 2, 2026

-21.54% (1Y)

Market Cap	1.18B -21.5%
Revenue (ttm)	1.10B +7.5%
Net Income	97.00M -45.3%
EPS	0.08 -45.3%
Shares Out	1.16B
PE Ratio	12.39
Forward PE	9.27
Dividend	n/a
Ex-Dividend Date	n/a

Volume	807,780
Open	1.030
Previous Close	1.040
Day's Range	1.020 - 1.030
52-Week Range	0.956 - 1.470
Beta	-0.07
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2026

About ADX:JULPHAR

Gulf Pharmaceutical Industries P.S.C., together with its subsidiaries, manufactures and sells medicines, drugs, and various other types of pharmaceutical, cosmetic, and medical compounds in United Arab Emirates, other GCC countries, and internationally. The company operates through Manufacturing, Trading, Investments, and Others segment. It offers generic medicines for pain and inflammation, antiviral, respiratory, anti-infectives, immunosuppressants and selective immunosuppressants, cardio care, CNS and psychiatry, vitamins and supplements, wo... [Read more]

Industry Pharmaceutical Preparations

Founded 1980

Employees 2,400

Stock Exchange Abu Dhabi Securities Exchange

Ticker Symbol JULPHAR

Full Company Profile

Financial Performance

In 2025, ADX:JULPHAR's revenue was 1.08 billion, an increase of 8.40% compared to the previous year's 992.20 million. Earnings were 172.20 million, an increase of 286.10%.

Financial Statements